This guide is aimed at community-level actors conducting Ebola preparedness activities. It covers key elements of general rumor management as well as specific rumors and possible responses to those rumors and includes a set of practical tools at the end.
This resource provides lessons from previous Ebola outbreaks in the DRC on adapting to the language needs of communities and centers language as a key trust builder between communities and public health experts.
This animated video addresses: What is Ebola? How is the virus transmitted? What are the signs and Symptoms?
2021- Developed by the Government of Sierra Leone, this resource features facts about Ebola, prevention, signs and symptoms, treatment and how to distinguish between COVID-19 and Ebola Virus Disease.
This fact sheet distinguishes between Covid-19 and Ebola in terms of cause, transmission, signs and symptoms and risk factors.
This message guide was produced in June 2016 to strengthen the coordination of the various information and education interventions developed to raise awareness about the Ebola epidemic in Côte d’Ivoire.
This resource (2018) provides a guide for RCCE work for the prevention and control of EVD outbreaks. The RCCE framework sets out overacting considerations regarding RCCE for preparedness and readiness to respond to outbreaks and links the RCCE response pillar to health technical areas.
This Guide was developed by the Yale Institute of Global Health and the UNICEF Demand for Immunization team. It is intended for public health professionals, communicators, advocates and anyone else who wishes to create pro-vaccine content to motivate people to vaccinate themselves and their entourage.
Source: Vaccine Messaging Guide
This WHO Ebola fact sheet (2021) provides comprehensive facts on Ebola, covering transmission, symptoms, prevention and control, vaccine, care for those recovered from Ebola and WHO response.
Source: WHO Ebola Fact Sheet
This fact sheet provides updated (2020) facts on Ebola Vaccines, addressing vaccine licensing, distribution, eligibility, adverse effects, ring vaccines and the role vaccines in outbreak control.
Source: Ebola FAQ’s (WHO)
This website is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the Health Communication Capacity Collaborative (HC3) Cooperative Agreement #AID-OAA-A-12-00058. On-going support is provided by Breakthrough ACTION with support from USAID's Bureau for Global Health, under Cooperative Agreement #AID-OAA-A-17-00017. Breakthrough ACTION is based at Johns Hopkins Center for Communication Programs (CCP). The contents of this website are the sole responsibility of Breakthrough ACTION and do not necessarily reflect the views of USAID, the United States Government, or Johns Hopkins University.